17-81940944-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001145113.3(MYADML2):c.798C>A(p.Asn266Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00058 in 1,550,476 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. N266N) has been classified as Likely benign.
Frequency
Consequence
NM_001145113.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYADML2 | NM_001145113.3 | c.798C>A | p.Asn266Lys | missense_variant | 3/3 | ENST00000409745.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYADML2 | ENST00000409745.2 | c.798C>A | p.Asn266Lys | missense_variant | 3/3 | 1 | NM_001145113.3 | P1 | |
PYCR1 | ENST00000579366.5 | c.-218C>A | 5_prime_UTR_variant | 1/4 | 3 | ||||
PYCR1 | ENST00000582198.5 | c.-24+1352C>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000302 AC: 47AN: 155590Hom.: 0 AF XY: 0.000327 AC XY: 27AN XY: 82608
GnomAD4 exome AF: 0.000606 AC: 847AN: 1398260Hom.: 3 Cov.: 34 AF XY: 0.000586 AC XY: 404AN XY: 689600
GnomAD4 genome AF: 0.000342 AC: 52AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.000296 AC XY: 22AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.798C>A (p.N266K) alteration is located in exon 3 (coding exon 1) of the MYADML2 gene. This alteration results from a C to A substitution at nucleotide position 798, causing the asparagine (N) at amino acid position 266 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at